Staff from Oxford University Hospitals NHS Foundation Trust have developed a new app called Let’s Talk Clots, to provide patients with information on blood clots and how to reduce the risk of them. Working in collaboration with Thrombosis UK, the team has created a free app, aimed at patients who are in hospital or who […]
Supercomputing study Sayan Roychowdhury of Duke University presents his team’s work on simulating cancer cell transport through the body. (Courtesy: Kevin Jackson) The SC23 conference, held earlier this month, broke previous audience records with over 14,000 attendees heading to Denver, CO, to find out about the latest achievements in high-performance computing (HPC). Like every other […]
According to a recent Reuters article, the United Kingdom has authorized the use of a gene therapy called Casgevy to treat sickle-cell disease and another inherited blood disorder in patients over the age of 12. The move marks the first instance of approval for a medicine using CRISPR, which was awarded the Nobel Prize in […]
Inching forward bumper to bumper on a highway when you’re on the way to an appointment, or worse, the airport, is enough to spike anyone’s blood pressure (BP). But researchers have found that a BP surge occurs independent of external stressors, and it could be due to the poor air flowing into the car from […]
Dr Sara Abdelmgeed (right) with host Lachlan Kitchen In the second episode of the ongoing podcast series, Know Plan Go: Protect Yourself from Respiratory Infections, by Gulf News in partnership with Pfizer, Dr Sara Abdelmgeed, a seasoned medical professional with over 11 years of clinical experience across Dubai and Egypt, discusses the connection between hypertension […]
November 28, 2023 3 min read A surge in respiratory disease in China appears to be caused by known pathogens, but the pattern of infections is still unusual By Nature magazine & Gemma Conroy Parents with children suffering from respiratory diseases line up at a children’s hospital in Chongqing, China, Epidemiology China is grappling with a surge in […]
Bristol Myers Squibb is further tapping into Avidity Biosciences for $100 million upfront to work on up to five cardiovascular targets. The Big Pharma wants more of the San Diego biotech’s RNA therapeutic work for its cardiovascular pipeline and is willing to dole out $60 million in cash, buy $40 million of Avidity stock at […]
Carolyn McLeod is walking the block outside the Chicago apartment where she and husband William are spending this year. Afterward, she’s planning to go out to eat Chinese food. She can feel her heart beating with her all along the way. “I’m feeling good,” she says. “I was able to trek a whole lot farther […]
Bristol Myers Squibb has agreed to spend at least $100 million to expand a partnership aimed at creating RNA-based medicines for cardiovascular diseases. The deal, announced Tuesday, shows Bristol Myers is willing to bet more on drugmaking technology developed by Avidity Biosciences. Founded in 2012, Avidity is trying to combine elements from two kinds of […]
Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs), today announced a global licensing and research collaboration with Bristol Myers Squibb (NYSE: BMY) focused on the discovery, development and commercialization of multiple cardiovascular targets with potential cumulative payments of up to $2.3 […]